Neuronetics Inc. (STIM)
Pitch Summary: Neuronetics (STIM) is positioned as the emerging platform leader in non-drug, non-invasive mental health treatment through its NeuroStar TMS system and recent Greenbrook TMS acquisition. The combined entity now controls the largest integrated TMS and esketamine therapy network in the U.S. (~400+ clinics). TMS is FDA-cleared, clinically validated, and gaining reimbursement traction, particularly […]